Clinical Data, Inc. · Newton, MA United States
| 1 Gateway Center, Ste. 702 | Phone: 617-527-9933 |
| Newton, MA | Fax: 617-965-0445 |
| 02458 | |
| United States |
Clinical Data, Inc. Rankings
Company Description
Clinical Data compiles drug research that it hopes will lead to blockbuster clinical trial results. The drug development company focuses on pharmaceutical candidates with an emphasis on treatments for central nervous system and psychiatric disorders, cardiovascular and ocular ailments, and cancers. Following a series of acquisitions, divestitures, and reorganizations, Clinical Data has focused its operations around its PGxHealth division, which engages in drug discovery research and clinical-stage drug development efforts. Its Viibryd antidepressant candidate was approved in 2011. Shortly after the drug's approval, the company was acquired by
To read the full description: Subscribe Now
Financials
| Company Type | Subsidiary |
|---|---|
| Fiscal Year-End | March |
| 2010 Employees | 177 |
Executives
16 executives listed for Clinical Data, Inc.'s Newton, MA location.
| Chairman | Randal Kirk | |
|---|---|---|
| President, CEO, and Director, Clinical Data and PGxHealth | Andrew Fromkin | |
| EVP and CFO, Clinical Data and PGxHealth | C. Evan Ballantyne |


